Suchergebnisse - "Facchin, Sonia"

PubPharm (52)

11

Salivary microbiota composition may discriminate between patients with eosinophilic oesophagitis ( EoE) and non‐EoE subjects

enthalten in: Alimentary Pharmacology & Therapeutics | 2022

von Facchin, S. | Calgaro, M. | Pandolfo, M. | +8

12

Editorial : non‐invasive testing for EoE—does microbiome testing hold the key? Authors' reply

enthalten in: Alimentary Pharmacology & Therapeutics | 2022

von Facchin, S. | Calgaro, M. | Pandolfo, M. | +4

13

Faecal Microbiome Transplantation as a Solution to Chronic Enteropathies in Dogs : A Case Study of Beneficial Microbial Evolution

enthalten in: Animals : an open access journal from MDPI | 2021

von Berlanda, M. | Innocente, G. | Simionati, B. | +7

14

Immunolocalization of leptin and leptin receptor in colorectal mucosa of ulcerative colitis, Crohn's disease and control subjects with no inflammatory bowel disease

enthalten in: Cell and tissue research | 2021

von Merigo, F. | Brandolese, A. | Facchin, S. | +6

15

Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases : A Multicentric Prospective Real-Life Study

enthalten in: Therapeutic advances in gastroenterology | 2021

von Massimi, D. | Barberio, B. | Bertani, L. | +9

16

Reply Letter to "Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes"

enthalten in: Neurogastroenterology and motility | 2021

von Facchin, S. | Buda, A. | Savarino, E.

CommentOn: Neurogastroenterol Motil. 2020 Oct;32(10):e13914. - PMID 32476236

17

Rapid point-of-care anti-infliximab antibodies detection in clinical practice : comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients

enthalten in: Therapeutic advances in gastroenterology | 2021

von Facchin, S. | Buda, A. | Cardin, R. | +8

18

Reply Letter to “Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes”

enthalten in: Neurogastroenterology & Motility | 2021

von Facchin, S. | Buda, A. | Savarino, E.

19

Immunolocalization of leptin and leptin receptor in colorectal mucosa of ulcerative colitis, Crohn’s disease and control subjects with no inflammatory bowel disease

enthalten in: Cell & tissue research | 2020

von Merigo, F. | Brandolese, A. | Facchin, S. | +6

20

Immunolocalization of leptin and leptin receptor in colorectal mucosa of ulcerative colitis, Crohn’s disease and control subjects with no inflammatory bowel disease

enthalten in: Cell & tissue research | 2020

von Merigo, F. | Brandolese, A. | Facchin, S. | +6